Scleromyxoedema-like changes in four renal dialysis patients

被引:57
作者
Hubbard, V
Davenport, A
Jarmulowicz, M
Rustin, M
机构
[1] Royal Free Hosp, Dept Dermatol, London NW3 2QG, England
[2] Royal Free Hosp, Dept Nephrol, London NW3 2QG, England
[3] Royal Free Hosp, Dept Histopathol, London NW3 2QG, England
关键词
renal dialysis; scleromyxoedema; toxic oil syndrome; vinyl chloride-induced scleroderma;
D O I
10.1046/j.1365-2133.2003.05181.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We describe four renal dialysis patients from our hospital who, over a 6-month period, developed erythematous, thickened, indurated dermal plaques. The plaques were limited to the limbs and in three patients there were associated flexion contractures. The clinical features most resembled scleromyxoedema. All patients had previously received at least one renal transplant. Histopathology of the plaques showed features of scleromyxoedema in two patients, whereas the other two showed a different picture, more suggestive of a morphoea-like process. There are important differences between our patients and classical scleromyxoedema. All four patients had normal immunoglobulins and no paraprotein was detected. Almost all cases of classical scleromyxoedema are associated with an IgGlambda paraproteinaemia. We have not yet identified an underlying cause for this cluster of cases in our hospital. It is possible that the skin changes seen may have been precipitated by an environmental agent, such as in 'toxic oil syndrome' and vinyl chloride-induced scleroderma. We discuss the differences between our patients and those with scleromyxoedema, localized or generalized morphoea and environmentally induced scleroderma. We feel that our patients show a constellation of features similar, but not identical, to scleromyxoedema. There has been only one previous report of similar patients. We believe this to be a new and distinct phenomenon.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 10 条
  • [1] Scleromyxoedema-like cutaneous diseases in renal-dialysis patients
    Cowper, SE
    Robin, HS
    Steinberg, SM
    Su, LD
    Gupta, S
    LeBoit, PE
    [J]. LANCET, 2000, 356 (9234) : 1000 - 1001
  • [2] SCLEROMYXEDEMA
    DINNEEN, AM
    DICKEN, CH
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (01) : 37 - 43
  • [3] CLINICAL EPIDEMIOLOGY OF TOXIC-OIL SYNDROME - MANIFESTATIONS OF A NEW ILLNESS
    KILBOURNE, EM
    RIGAUPEREZ, JG
    HEATH, CW
    ZACK, MM
    FALK, H
    MARTINMARCOS, M
    DECARLOS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (23) : 1408 - 1414
  • [4] LELBACH WK, 1981, ADV INTERNAL MED PED, V47, P1
  • [5] Marzano AV, 1997, BRIT J DERMATOL, V136, P598
  • [6] NORIEGA AR, 1982, LANCET, V2, P697
  • [7] ANTIHISTONE ANTIBODIES IN PATIENTS WITH LOCALIZED SCLERODERMA
    SATO, S
    IHN, H
    SOMA, Y
    IGARASHI, A
    TAMAKI, T
    KIKUCHI, K
    ISHIBASHI, Y
    TAKEHARA, K
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (08): : 1137 - 1141
  • [8] SUCIU I, 1963, Med Interna (Bucur), V15, P967
  • [9] ANTI-NUCLEAR ANTIBODIES IN LOCALIZED SCLERODERMA
    TAKEHARA, K
    MOROI, Y
    NAKABAYASHI, Y
    ISHIBASHI, Y
    [J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (05): : 612 - 616
  • [10] THE ASSOCIATION OF POTENTIALLY LETHAL NEUROLOGIC SYNDROMES WITH SCLEROMYXEDEMA (PAPULAR MUCINOSIS)
    WEBSTER, GF
    MATSUOKA, LY
    BURCHMORE, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 28 (01) : 105 - 108